{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:00:46Z","timestamp":1757541646193,"version":"3.37.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s13721-022-00392-0","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:03:41Z","timestamp":1667865821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Plectin as a putative novel biomarker for breast cancer: an in silico study"],"prefix":"10.1007","volume":"11","author":[{"given":"Madhushree M. V.","family":"Rao","sequence":"first","affiliation":[]},{"given":"M.","family":"Likith","sequence":"additional","affiliation":[]},{"given":"R.","family":"Kavya","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0596-1121","authenticated-orcid":false,"given":"T. P. N.","family":"Hariprasad","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"issue":"8","key":"392_CR1","first-page":"2546","volume":"10","author":"R Anita","year":"2020","unstructured":"Anita R, Paramasivam A, Priyadharsini JV, Chitra S (2020) The m6A readers YTHDF1 and YTHDF3 aberrations associated with metastasis and predict poor prognosis in breast cancer patients. Am J Cancer Res 10(8):2546\u20132554","journal-title":"Am J Cancer Res"},{"issue":"11","key":"392_CR2","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1007\/s11605-009-1001-9","volume":"13","author":"D Bausch","year":"2009","unstructured":"Bausch D, Mino-Kenudson M, Castillo FC, Warshaw AL, Kelly KA, Thayer SP (2009) Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms. J Gastrointest Surg 13(11):1948\u20131954. https:\/\/doi.org\/10.1007\/s11605-009-1001-9","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"392_CR3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1158\/1078-0432","volume":"17","author":"D Bausch","year":"2011","unstructured":"Bausch D, Thomas S, Mino-Kenudson M, Fern\u00e1ndez-del CC, Bauer TW, Williams M, Warshaw AL, Thayer SP, Kelly KA (2011) Plectin-1 as a novel biomarker for pancreatic cancer. Clin Cancer Res 17(2):302\u2013309. https:\/\/doi.org\/10.1158\/1078-0432","journal-title":"Clin Cancer Res"},{"key":"392_CR4","first-page":"2127","volume":"8","author":"MF Buckley","year":"1993","unstructured":"Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127\u20132133","journal-title":"Oncogene"},{"issue":"3","key":"392_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41388-020-01557-9","volume":"40","author":"M Buckup","year":"2021","unstructured":"Buckup M, Rice MA, HsuEC G-M, Liu S, Aslan M, Bermudez A, Huang J, Pitteri SJ, Stoyanova T (2021) Plectin is a regulator of prostate cancer growth and metastasis. Oncogene 40(3):663\u2013676. https:\/\/doi.org\/10.1038\/s41388-020-01557-9","journal-title":"Oncogene"},{"issue":"5","key":"392_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065005","volume":"8","author":"TC Burch","year":"2013","unstructured":"Burch TC, Watson MT, Nyalwidhe JO (2013) Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells. PLoS ONE 8(5):e65005. https:\/\/doi.org\/10.1371\/journal.pone.0065005","journal-title":"PLoS ONE"},{"issue":"8","key":"392_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BV, Varambally S (2017) UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19(8):649\u2013658. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002","journal-title":"Neoplasia"},{"issue":"7","key":"392_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3349\/ymj.2019.60.7.611","volume":"60","author":"C Chen","year":"2019","unstructured":"Chen C, Li HF, Hu YJ, Jiang MJ, Liu QS, Zhou J (2019) Family with sequence similarity 83 member H promotes the viability and metastasis of cervical cancer cells and indicates a poor prognosis. Yonsei Med J 60(7):611\u2013618. https:\/\/doi.org\/10.3349\/ymj.2019.60.7.611","journal-title":"Yonsei Med J"},{"issue":"22","key":"392_CR9","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/jnci\/djr393","volume":"103","author":"M Dowsett","year":"2011","unstructured":"Dowsett M, Nielsen TO, A\u2019Hern R, Bartlett J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, McShane L, Paik S, Penault-Llorca F, Prudkin L, Regan M, Salter J, Sotiriou C, Smith IE, Viale G, Zujewski JA, Hayes DF (2011) International Ki-67 in Breast Cancer Working Group. J Natl Cancer Inst 103(22):1656\u20131664. https:\/\/doi.org\/10.1093\/jnci\/djr393","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"392_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","volume":"5","author":"Y Feng","year":"2018","unstructured":"Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, Ji X, Liu W, Huang B, Luo W, Liu B, Lei Y, Du S, Vuppalapati A, Luu HH, Haydon RC, He TC, Ren G (2018) Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis 5(2):77\u2013106. https:\/\/doi.org\/10.1016\/j.gendis.2018.05.001","journal-title":"Genes Dis"},{"issue":"269","key":"392_CR11","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6(269):pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088","journal-title":"Sci Signal"},{"issue":"6","key":"392_CR12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cub.2015.01.010","volume":"25","author":"P Gaspar","year":"2015","unstructured":"Gaspar P, Holder MV, Aerne BL, Janody F, Tapon N (2015) Zyxin antagonizes the FERM protein expanded to couple F-actin and Yorkie-dependent organ growth. Curr Biol 25(6):679\u2013689. https:\/\/doi.org\/10.1016\/j.cub.2015.01.010","journal-title":"Curr Biol"},{"key":"392_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.08.898965","author":"S Guerrero","year":"2020","unstructured":"Guerrero S, L\u00f3pez-Cort\u00e9s A, Garc\u00eda-C\u00e1rdenas JM, Armend\u00e1riz-Castillo I, Zambrano AK, Indacochea A, P\u00e9rez-Villa A, Yumiceba V, Guevara-Ram\u00edrez P, Alvarado AJ, Leone PE, Paz-y-Mi\u00f1o C (2020) In silico analyses reveal new putative Breast Cancer RNA-binding proteins. BioRxiv. https:\/\/doi.org\/10.1101\/2020.01.08.898965","journal-title":"BioRxiv"},{"key":"392_CR14","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1007\/s10549-009-0674-9","volume":"19","author":"B Gy\u0151rffy","year":"2021","unstructured":"Gy\u0151rffy B (2021) Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct Biotechnol J 19:4101\u20134109. https:\/\/doi.org\/10.1007\/s10549-009-0674-9","journal-title":"Comput Struct Biotechnol J"},{"issue":"16","key":"392_CR15","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.5858\/134.7.e48","volume":"28","author":"MEH Hammond","year":"2010","unstructured":"Hammond MEH, Hayes DF, Dowsett M et al (2010) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immune histochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28(16):2784\u20132795. https:\/\/doi.org\/10.5858\/134.7.e48","journal-title":"J Clin Oncol"},{"issue":"2","key":"392_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molonc.2012.01.010","volume":"6","author":"NL Henry","year":"2012","unstructured":"Henry NL, Hayes DF (2012) Cancer biomarkers. Mol Oncol 6(2):140\u2013146. https:\/\/doi.org\/10.1016\/j.molonc.2012.01.010","journal-title":"Mol Oncol"},{"issue":"10","key":"392_CR17","first-page":"3056","volume":"5","author":"L Hu","year":"2015","unstructured":"Hu L, Wu Y, Guan X, Liang Y, Yao X, Tan D, Bai Y, Xiong G, Yang K (2015) Germline copy number loss of UGT2B28 and gain of PLEC contribute to increased human esophageal squamous cell carcinoma risk in Southwest China. Am J Cancer Res 5(10):3056\u20133071","journal-title":"Am J Cancer Res"},{"key":"392_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/s12885-018-4388-4","volume":"18","author":"S Huang","year":"2018","unstructured":"Huang S, Murphy L, Xu W (2018) Genes and functions from breast cancer signatures. BMC Cancer 18:473. https:\/\/doi.org\/10.1186\/s12885-018-4388-4","journal-title":"BMC Cancer"},{"key":"392_CR19","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fonc.2020.00621","volume":"10","author":"Q Huo","year":"2020","unstructured":"Huo Q, Li Z, Cheng L, Yang F, Xie N (2020) SIRT7 is a prognostic biomarker associated with immune infiltration in luminal breast cancer. Front Oncol 10:621. https:\/\/doi.org\/10.3389\/fonc.2020.00621","journal-title":"Front Oncol"},{"key":"392_CR20","doi-asserted-by":"publisher","unstructured":"J\u00e9z\u00e9quel P, Fr\u00e9nel JS, Campion L, Gu\u00e9rin-Charbonnel C, Gouraud W, Ricolleau G, Campone M (2013) bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses. Database bas060. doi: https:\/\/doi.org\/10.1093\/database\/bas060","DOI":"10.1093\/database\/bas060"},{"key":"392_CR21","doi-asserted-by":"publisher","unstructured":"J\u00e9z\u00e9quel P, Gouraud W, Azzouz FB, Gu\u00e9rin-Charbonnel C, Juin PP, Lasla H, Campone M (2021) bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses. Database baab007. doi:https:\/\/doi.org\/10.1093\/database\/baab007","DOI":"10.1093\/database\/baab007"},{"issue":"18","key":"392_CR22","doi-asserted-by":"publisher","first-page":"7442","DOI":"10.18632\/aging.102250","volume":"11","author":"X Jing","year":"2019","unstructured":"Jing X, Liang H, Hao C, Hongxia L, Cui X (2019) Analyses of an epigenetic switch involved in the activation of pioneer factor FOXA1 leading to the prognostic value of estrogen receptor and FOXA1 co-expression in breast cancer. Aging 11(18):7442\u20137456. https:\/\/doi.org\/10.18632\/aging.102250","journal-title":"Aging"},{"issue":"6","key":"392_CR23","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.jprot.2011.12.018","volume":"75","author":"K Katada","year":"2012","unstructured":"Katada K, Tomonaga T, Satoh M, Matsushita K, Tonoike Y, Kodera Y, Hanazawa T, Nomura F, Okamoto Y (2012) Plectin promotes migration and invasion of cancer cells and is a novel prognostic marker for head and neck squamous cell carcinoma. J Proteomics 75(6):1803\u20131815. https:\/\/doi.org\/10.1016\/j.jprot.2011.12.018","journal-title":"J Proteomics"},{"key":"392_CR24","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1038\/s41598-017-03639-3","volume":"7","author":"KM Kim","year":"2017","unstructured":"Kim KM, Park SH, Bae JS, Noh SJ, Tao GZ, Kim JR, Kwon KS, Park HS, Park BH, Lee H, Chung MJ, Moon WS, Sylvester KG, Jang KY (2017) FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC. Sci Rep 7:3274. https:\/\/doi.org\/10.1038\/s41598-017-03639-3","journal-title":"Sci Rep"},{"key":"392_CR25","doi-asserted-by":"publisher","first-page":"34472","DOI":"10.1038\/srep34472","volume":"6","author":"T Kuga","year":"2016","unstructured":"Kuga T, Kume H, Adachi J, Kawasaki N, Shimizu M, Hoshino I, Matsubara H, Saito Y, Nakayama Y, Tomonaga T (2016a) Casein kinase 1 is recruited to nuclear speckles by FAM83H and SON. Sci Rep 6:34472. https:\/\/doi.org\/10.1038\/srep34472","journal-title":"Sci Rep"},{"key":"392_CR26","doi-asserted-by":"publisher","first-page":"26557","DOI":"10.1038\/srep26557","volume":"6","author":"T Kuga","year":"2016","unstructured":"Kuga T, Sasaki M, Mikami T, Miake Y, Adachi J, Shimizu M, Saito Y, Koura M, Takeda Y, Matsuda J, Tomonaga T, Nakayama Y (2016b) FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes. Sci Rep 6:26557. https:\/\/doi.org\/10.1038\/srep26557","journal-title":"Sci Rep"},{"issue":"1\u20136","key":"392_CR27","first-page":"141","volume":"35","author":"KY Lee","year":"2004","unstructured":"Lee KY, Liu YH, Ho CC, Pei RJ, Yeh KT, Cheng CC, Lai YS (2004) An early evaluation of malignant tendency with plectin expression in human colorectal adenoma and adenocarcinoma. J Med 35(1\u20136):141\u2013149","journal-title":"J Med"},{"issue":"1","key":"392_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0962-8924(01)02180-8","volume":"12","author":"CL Leung","year":"2002","unstructured":"Leung CL, Green KJ, Liem RK (2002) Plakins: a family of versatile cytolinker proteins. Trends Cell Biol 12(1):37\u201345. https:\/\/doi.org\/10.1016\/S0962-8924(01)02180-8","journal-title":"Trends Cell Biol"},{"issue":"21","key":"392_CR29","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS (2017) TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res 77(21):e108\u2013e110. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307","journal-title":"Cancer Res"},{"key":"392_CR30","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1158\/1078-0432.CCR-07-5026","volume":"14","author":"XJ Ma","year":"2008","unstructured":"Ma XJ, Salunga R, Dahiya S, Wang W, Carney E, Durbecq V, Harris A, Goss P, Sotiriou C, Erlander M, Sgroi D (2008) A five gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer. Clin Cancer Res 14:2601\u20132608. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-5026","journal-title":"Clin Cancer Res"},{"issue":"11","key":"392_CR31","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/mc.22425","volume":"55","author":"AK Nalla","year":"2016","unstructured":"Nalla AK, Williams TF, Collins CP, Rae DT, Trobridge GD (2016) Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome. Mol Carcinog 55(11):1761\u20131771. https:\/\/doi.org\/10.1002\/mc.22425","journal-title":"Mol Carcinog"},{"issue":"11","key":"392_CR33","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1111\/j.1349-7006.2009.01282.x","volume":"100","author":"T Niwa","year":"2009","unstructured":"Niwa T, Saito H, Imajoh-ohmi S, Kaminishi M, Seto Y, Miki Y, Nakanishi A (2009) BRCA2 interacts with the cytoskeletal linker protein plectin to form a complex controlling centrosome localization. Cancer Sci 100(11):2115\u20132125. https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01282.x","journal-title":"Cancer Sci"},{"issue":"27","key":"392_CR34","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N (2004) A multigene assay topredict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351(27):2817\u20132826. https:\/\/doi.org\/10.1056\/NEJMoa041588","journal-title":"N Engl J Med"},{"issue":"6","key":"392_CR35","doi-asserted-by":"publisher","first-page":"510","DOI":"10.4161\/cbt.12.6.16833","volume":"12","author":"H Pawar","year":"2011","unstructured":"Pawar H, Kashyap MK, Sahasrabuddhe NA, Renuse S, Harsha HC, Kumar P, Sharma J, Kandasamy K, Marimuthu A, Nair B, Rajagopalan S, Maharudraiah J, Premalatha JS, Kumar KVV, Vijayakumar M, Chaerkady R, Keshava Prasad TS, Kumar RV, Kumar RV, Pandey A (2011) Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery. Cancer Biol Ther 12(6):510\u2013522. https:\/\/doi.org\/10.4161\/cbt.12.6.16833","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"392_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5442-6","volume":"19","author":"MT Phung","year":"2019","unstructured":"Phung MT, Tin ST, Elwood JM (2019) Prognostic models for breast cancer: a systematic review. BMC Cancer 19(1):1\u201318","journal-title":"BMC Cancer"},{"issue":"1","key":"392_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12903-015-0084-9","volume":"15","author":"OG Rikardsen","year":"2015","unstructured":"Rikardsen OG, Magnussen SN, Svineng G, Hadler-Olsen E, Uhlin-Hansen L, Steigen SE (2015) Plectin as a prognostic marker in non-metastatic oral squamous cell carcinoma. BMC Oral Health 15(1):1\u20138. https:\/\/doi.org\/10.1186\/s12903-015-0084-9","journal-title":"BMC Oral Health"},{"key":"392_CR38","first-page":"2537","volume":"61","author":"P Roger","year":"2001","unstructured":"Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H (2001) Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61:2537\u20132541","journal-title":"Cancer Res"},{"issue":"2","key":"392_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/1878-0261.12016","volume":"11","author":"AM Snijders","year":"2017","unstructured":"Snijders AM, Lee SY, Hang B, Hao W, Bissell MJ, Mao JH (2017) FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach. Mol Oncol 11(2):167\u2013179. https:\/\/doi.org\/10.1002\/1878-0261.12016","journal-title":"Mol Oncol"},{"issue":"4","key":"392_CR40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jnci\/djj052","volume":"98","author":"C Sotiriou","year":"2006","unstructured":"Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H, Nuyten D, Buyse M, van de Vijver MJ, Bergh J, Piccart M, Delorenzi M (2006) Gene expressionprofiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98(4):262\u2013272. https:\/\/doi.org\/10.1093\/jnci\/djj052","journal-title":"J Natl Cancer Inst"},{"key":"392_CR41","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z (2017) GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45:W98\u2013W102. https:\/\/doi.org\/10.1093\/nar\/gkx247","journal-title":"Nucleic Acids Res"},{"issue":"6871","key":"392_CR42","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ Van't Veer","year":"2002","unstructured":"Van\u2019t Veer LJ, Dai H, Van De Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871):530\u2013536. https:\/\/doi.org\/10.1038\/415530a","journal-title":"Nature"},{"key":"392_CR43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(05)17947-1","volume":"365","author":"Y Wang","year":"2005","unstructured":"Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, YangF TD, Timmermans M, Meijer-van Gelder ME, Yu J (2005) Gene expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365:671\u2013679. https:\/\/doi.org\/10.1016\/S0140-6736(05)17947-1","journal-title":"Lancet"},{"issue":"17","key":"392_CR44","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1242\/jcs.111.17.2477","volume":"111","author":"G Wiche","year":"1998","unstructured":"Wiche G (1998) Role of plectin in cytoskeleton organization and dynamics. J Cell Sci 111(17):2477\u20132486. https:\/\/doi.org\/10.1242\/jcs.111.17.2477","journal-title":"J Cell Sci"},{"issue":"1","key":"392_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","volume":"25","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond MEH, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF (2007) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118\u2013145. https:\/\/doi.org\/10.1200\/JCO.2006.09.2775","journal-title":"J Clin Oncol"},{"key":"392_CR46","unstructured":"World Health Organization (2021) https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer accessed 08 September 2021"},{"issue":"2","key":"392_CR47","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1021\/acs.nanolett.7b04307","volume":"18","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, Du C, Sun C, Zhu J, Wu S, Zhang Y, Ji T, Lei J, Yang Y, Gao N, Nie G (2018) Chaperonin-GroEL as a smart hydrophobic drug delivery and tumor targeting molecular machine for tumor therapy. Nano Lett 18(2):921\u2013928. https:\/\/doi.org\/10.1021\/acs.nanolett.7b04307","journal-title":"Nano Lett"},{"key":"392_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fonc.2020.00068","volume":"10","author":"H Zheng","year":"2020","unstructured":"Zheng H, Zhang G, Zhang L, Wang Q, Li H, Han Y, Xie L, Yan Z, Li Y, An Y, Dong H, Zhu W, Guo X (2020) Comprehensive review of web servers and bioinformatics tools for cancer prognosis analysis. Front Oncol 10:68. https:\/\/doi.org\/10.3389\/fonc.2020.00068","journal-title":"Front Oncol"},{"issue":"4","key":"392_CR49","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/cancers14040934","volume":"14","author":"L Zhou","year":"2022","unstructured":"Zhou L, Rueda M, Alkhateeb A (2022) Classification of breast cancer Nottingham Prognostic Index using High-Dimensional Embedding and Residual Neural Network. Cancers 14(4):934","journal-title":"Cancers"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-022-00392-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13721-022-00392-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-022-00392-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T08:00:17Z","timestamp":1670054417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13721-022-00392-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["392"],"URL":"https:\/\/doi.org\/10.1007\/s13721-022-00392-0","relation":{},"ISSN":["2192-6662","2192-6670"],"issn-type":[{"type":"print","value":"2192-6662"},{"type":"electronic","value":"2192-6670"}],"subject":[],"published":{"date-parts":[[2022,11,7]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not involve any ethical issues.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"This study does not involve any animal or human subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate (Ethics)"}},{"value":"This study does not require any consent to publish as no animal or human participants were involved in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish (Ethics)"}}],"article-number":"49"}}